Avid Bioservices (CDMO) Misses Q1 EPS by 1c, beats revenue, offers guidance

Avid Bioservices (NASDAQ: CDMO) reported Q1 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $37.7 million versus the consensus estimate of $37.06 million.

GUIDANCE:

Avid Bioservices sees FY 2024 revenue of $145-165 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Ennis (EBF) Reports In-Line Q1 EPS
• Carnival shares drop despite earnings beat on weak guidance